Hormone therapies have played a major role in improving survival for patients with ER+ breast cancer [1]. By blocking or reducing estrogen’s impact, these treatments slow the cancer’s growth ...

Breastfeeding is widely recognized for its role in infant nutrition ... suppresses estrogen, a hormone linked to Hormonal Receptor positive breast cancer (HR-positive). 1 Additionally, breast ...

The Data On AI Usage In Breast Cancer Screening And Diagnosis Research has revealed the crucial role AI can play in breast ... a radiologist will review the images at hand, whether from a ...

ER+/PR+ breast cancer is a subtype of ER positive breast cancer where the tumor cells express both estrogen receptors (ER) and progesterone receptors (PR) on the surface. As the most common type ...

While it’s true that soy isoflavones play a bigger role in estrogen-receptor positive breast cancers, early research links it to a lower risk of other types of breast cancer. That finding comes ...

‘#Estrogens weaken the immune system's ability to attack tumors and reduce the effectiveness of #immunotherapy against #cancer. #medindia’ Researchers explain how estrogens limit ...

Elacestrant (Orserdu) is an oral drug that binds to estrogen receptors used to treat postmenopausal women or men with certain types of advanced breast cancer with an ESR1 mutation. Abemaciclib ...

Despite improved treatments and a significant rise in the number of survivors, breast cancer still stands ... compounds can mimic or oppose estrogen effects, offering new angles in understanding ...

Long-term estrogen imbalance can lead to more serious health problems, such as fibroids, endometriosis, or an increased risk of developing certain types of cancer, including breast cancer.

Credit: Getty Images. Researchers found modest decreases in the risk of breast cancer-specific death and all-cause death among patients who used vaginal estrogen therapy. Vaginal estrogen therapy ...